Home » Newsletters » BioWorld

BioWorld

Aug. 28, 1996

View Archived Issues

OTHER NEWS TO NOTE

SUPERGEN GAINING RIGHTS TO APPLICATIONS OF INFLAZYME DRUGS

T CELL SCIENCES SELLS 5M SHARES IN PUBLIC OFFERING, GROSSES $11M

RESEARCHERS PINPOINT GENE THAT CAUSES RARE INHERITED DISEASE RESULTING

IMMUNOMEDICS SEEKS $60M IN DAMAGES FROM PHARMACIA & UPJOHN

AVIRON STARTS PHASE III OF INFLUENZA VACCINE; EYES 1999 MARKET LAUNCH